Literature DB >> 28250748

Neuroprotective effects of vascular endothelial growth factor A in the experimental autoimmune encephalomyelitis model of multiple sclerosis.

Wensheng Lin1.   

Abstract

Entities:  

Year:  2017        PMID： 28250748      PMCID： PMC5319243          DOI： 10.4103/1673-5374.198982

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN： 1673-5374            Impact factor:   5.135


× No keyword cloud information.
  10 in total

Review 1.  Pathology of demyelinating diseases.

Authors:  Bogdan F Gh Popescu; Claudia F Lucchinetti
Journal:  Annu Rev Pathol       Date:  2012       Impact factor: 23.472

2.  VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.

Authors:  W A Roscoe; M E Welsh; D E Carter; S J Karlik
Journal:  J Neuroimmunol       Date:  2009-02-23       Impact factor: 3.478

Review 3.  VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration.

Authors:  Peter Carmeliet; Carmen Ruiz de Almodovar; Ruiz de Almodovar Carmen
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

Review 4.  Role and therapeutic potential of VEGF in the nervous system.

Authors:  Carmen Ruiz de Almodovar; Diether Lambrechts; Massimiliano Mazzone; Peter Carmeliet
Journal:  Physiol Rev       Date:  2009-04       Impact factor: 37.312

5.  Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis.

Authors:  Wensheng Lin; Yifeng Lin; Jin Li; Ali G Fenstermaker; Sharon W Way; Benjamin Clayton; Stephanie Jamison; Heather P Harding; David Ron; Brian Popko
Journal:  J Neurosci       Date:  2013-04-03       Impact factor: 6.167

6.  PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.

Authors:  Yifeng Lin; Guangcun Huang; Stephanie Jamison; Jin Li; Heather P Harding; David Ron; Wensheng Lin
Journal:  Am J Pathol       Date:  2013-11-19       Impact factor: 4.307

7.  Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke.

Authors:  Janet Shimotake; Nikita Derugin; Michael Wendland; Zinaida S Vexler; Donna M Ferriero
Journal:  Stroke       Date:  2010-02       Impact factor: 7.914

Review 8.  Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.

Authors:  Manuel A Friese; Benjamin Schattling; Lars Fugger
Journal:  Nat Rev Neurol       Date:  2014-03-18       Impact factor: 42.937

Review 9.  Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Francesco Girolamo; Cristiana Coppola; Domenico Ribatti; Maria Trojano
Journal:  Acta Neuropathol Commun       Date:  2014-07-22       Impact factor: 7.801

10.  Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.

Authors:  Milos Stanojlovic; Xiaosha Pang; Yifeng Lin; Sarrabeth Stone; Marija Cvetanovic; Wensheng Lin
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240
  10 in total
  5 in total

Review 1.  Laminin as a Biomarker of Blood-Brain Barrier Disruption under Neuroinflammation: A Systematic Review.

Authors:  Juan F Zapata-Acevedo; Valentina García-Pérez; Ricardo Cabezas-Pérez; Monica Losada-Barragán; Karina Vargas-Sánchez; Rodrigo E González-Reyes
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

2.  Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.

Authors:  Francesco Girolamo; Mariella Errede; Giovanna Longo; Tiziana Annese; Carlotta Alias; Giovanni Ferrara; Sara Morando; Maria Trojano; Nicole Kerlero de Rosbo; Antonio Uccelli; Daniela Virgintino
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

Review 3.  Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches.

Authors:  Maria Teresa Gentile; Gianluca Muto; Giacomo Lus; Karl-Olof Lövblad; Åsa Fex Svenningsen; Luca Colucci-D'Amato
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

4.  Neuroprotective effects of exercise in people with progressive multiple sclerosis (Exercise PRO-MS): study protocol of a phase II trial.

Authors:  A S Gravesteijn; H Beckerman; B A de Jong; H E Hulst; V de Groot
Journal:  BMC Neurol       Date:  2020-05-11       Impact factor: 2.474

5.  Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.

Authors:  Yuan Yue; Milos Stanojlovic; Yifeng Lin; Gerard Karsenty; Wensheng Lin
Journal:  J Neuroinflammation       Date:  2019-02-01       Impact factor: 8.322
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.